To the Editor: An important concern with respect to protecting human research participants is that institutional review boards (IRBs) have insufficient resources.1 However, there are few reports of the actual costs of IRB review.2–4 To estimate the cost of operating academic IRBs in 2002, we undertook a survey with the support of the Doris Duke Charitable Foundation and the Burroughs Wellcome Fund. We surveyed 121 U.S. medical schools with active IRBs; 63 representative institutions responded. Institutions documented the education, experience, and job titles of IRB staff; the composition of the IRB itself; the estimated amounts of time spent on . . .
No takes yet. Share an insight, caveat, or question.
Sugarman et al. (2005) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: